// App-Quantinova.ai

: Mapping associations across multiple aspects of Alzheimer disease and the role of CSF biomarkers in individuals without dementia.

Researchers

Presenter

  • Lisa Waterink

Principal Investigators

  • Marissa D. Zwan

  • Frederik Barkhof

  • Casper de Boer

  • Silvia Ingala

  • Luigi Lorenzini

  • Graciela Muñiz‐Terrera

  • Craig W. Ritchie

  • Pieter Jelle Visser

  • Wiesje M. van der Flier

  • Charlotte E. Teunissen

  • Katrijn van Deun

  • Lisa Vermunt

Medical Centers

  • Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam university medical center

  • Centre for Dementia Prevention, University of Edinburgh

  • Department of Anatomy and Neurosciences, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC

  • Amsterdam University Medical Centers, Amsterdam

  • Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam university medical center

  • Tilburg School of Social and Behavioral Sciences, Department of Methodology, Tilburg University

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Alzheimer's disease

  • Dementia

Biomarkers

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A